00000000nam 2200000zi 4500
0019.941916
003CaOODSP
00520250328114716
006m     o  d f      
007cr cn ||||||||
008240815t20252025oncd    ob   f000 0 eng d
020 |a9780660763408
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-382/2025E-PDF
24500|aGuidance document : |bthe regulatory enrolment process (REP) : drugs for human/veterinary use, disinfectants, and biocides.
24630|aRegulatory enrolment process (REP) : |bhuman/veterinary use, disinfectants, and biocides
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2025.
264 4|c©2025
300 |a1 online resource (27 pages) : |bcharts
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : processus d'inscription réglementaire (PIR) : médicaments à usage humain, à usage vétérinaire, désinfectants et biocides.
500 |a"Effective date: 2025/05/31."
504 |aIncludes bibliographical references.
650 0|aPharmaceutical policy|zCanada.
650 0|aDrugs|xGovernment policy|zCanada.
650 0|aVeterinary drugs|xGovernment policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLigne directrice : |w(CaOODSP)9.941915
85640|qPDF|s624 KB|uhttps://publications.gc.ca/collections/collection_2025/sc-hc/H164-382-2025-eng.pdf
986 |a240966